Intellectual Property UK

  • April 22, 2024

    Pfizer, Moderna Set To Tee Off Over COVID-19 Vaccine Patents

    A London court is poised to consider Tuesday whether Pfizer infringed patents that Moderna initially pledged to not enforce, marking the first time a court has weighed in on the topic.

  • April 22, 2024

    Abbott Says Rival Can Make Diabetes Tech Without TM Shape

    An Abbott Laboratories unit is defending a 3D trademark it owns over its continuous glucose monitoring devices, arguing that it is the only company offering a device in that distinctive circular shape despite Sinocare Inc. and other rivals' arguments to the contrary.

  • April 22, 2024

    EUIPO Sets Out New Policies For TMs With Morality Woes

    The European Union Intellectual Property Office said Friday it has begun the three-month roll-out for new rules governing morality principles in trademark registration, marking the first time the EU has taken a harmonized approach to the subject.

  • April 22, 2024

    Sandoz Gets Jazz's Cancer Treatment Patent Nixed

    Jazz Pharmaceuticals has lost a patent for fat-based drug preparations to treat cancer after European officials ruled that it wasn't innovative.

  • April 22, 2024

    HR Software Giant Can Fight On To Register 'Standout' TM

    American software giant ADP will have a second chance to attempt to register the word "standout" as a trademark in the European Union, even though the bloc's intellectual property authority decided that the mark failed to meet basic trademark requirements.

  • April 22, 2024

    Kirkland-Led Blackstone Bids $1.2B For Music Biz Hipgnosis

    Private equity firm Blackstone has tabled an enhanced $1.2 billion bid for U.K. music royalties investment company Hipgnosis, countering an offer from U.S. royalties firm Concord Chorus.

  • April 19, 2024

    Royal Mail Accuses Developer Of Copying Postcode Database

    Royal Mail has accused a software developer of using its database of postcode information to set up its own address-finding company.

  • April 19, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen U.K. holiday resort chain Butlins target Aviva and a huddle of insurers, Meta and WhatsApp tackle a patents claim by telecommunications company Semitel, an ongoing construction dispute between Essex County Council and Balfour Beatty, and Formycon AG hit a pharmaceutical company for infringing medical products. Here, Law360 looks at these and other new claims in the U.K.

  • April 19, 2024

    UKIPO Halts Takeoff For Admin-Based Aircraft Docking Patent

    An engineering company cannot protect its aircraft docking invention with a U.K. patent because it is an administrative activity which is outside the realms of patentability, the nation's Intellectual Property Office has ruled.

  • April 19, 2024

    'Oktoberfest' Too Descriptive For Munich To Get TM

    The city of Munich has failed to revive its "Oktoberfest" trademark protections over beer glasses and clothing after a European Union appeals panel ruled that the sign is too descriptive of the festival-inspired style of the goods.

  • April 19, 2024

    5 Questions For Taylor Wessing's Roland Mallinson

    Roland Mallinson had dreamed as a child of becoming an architect, but a teacher set him on a different course, steering him toward the path of civil engineering before he eventually became an intellectual property lawyer.

  • April 18, 2024

    Patent Court Edges Closer To Transparency With Ocado Decision

    The Unified Patent Court gave an early signal this month about its willingness to make proceedings transparent by agreeing to let an outside lawyer see pleadings in a high-profile case, but some lawyers warned that the court had not gone far enough to guarantee openness at the new court.

  • April 18, 2024

    Ericsson Can't Push Lenovo's FRAND Claim Out Of UK

    Swedish telecom Ericsson has failed to force Lenovo's claim over patent licensing terms out of the U.K., as a London judge on Thursday concluded that the English courts are "clearly the most appropriate" forum for the Chinese multinational's case.

  • April 18, 2024

    Dexcom Asks EU Court To Toss Abbott Med Tech Patent

    Medical device maker Dexcom Inc. has asked Europe's patent court to revoke Abbott Diabetes Care Inc.'s patent for glucose monitor screens, firing back at its rival in a sprawling international battle over the technology.

  • April 18, 2024

    Truffle Specialist Can't Protect 'Cipriani Tartufi' TM In EU

    An Italian truffle distributor cannot register his "Cipriani Tartufi" trademark in the European Union because it is too similar to a luxury food specialist's "Cipriani Food" branding, an intellectual property appeals panel in the bloc has ruled.

  • April 25, 2024

    Mathys & Squire Recruits New IP Partner To Munich Office

    Mathys & Squire LLP has hired a new intellectual property partner in its Munich office from Müller Hoffmann & Partner in its latest move toward delivering all-German advice to clients in the nation.

  • April 17, 2024

    Escobar TM Too Shocking For General Public, EU Court Rules

    A European court refused Wednesday to let cocaine kingpin Pablo Escobar's family trademark his name because of its "highly offensive and shocking" associations with drug trafficking and narcoterrorism.

  • April 17, 2024

    Coinbase Loses EU Appeal To Bloc Rival TM

    Coinbase lost part of its bid Wednesday to stop an Estonian company bearing the same name from registering a trademark, with a European court saying the cryptocurrency platform cannot block the trademark of the Baltic state business for news services, publishing or education.

  • April 17, 2024

    Ireland Pushes Back UPC Ratification Vote

    The Irish government has pushed back the date for a referendum to decide whether it should ratify the agreement to join Europe's Unified Patent Court, citing the need for more public engagement on the matter.

  • April 17, 2024

    Chinese Vape Maker Accuses UK Co. Of Bumming Designs

    A Chinese vape maker has accused a rival of selling products that look identical to its SKE Crystal Bar, infringing its intellectual property by using the "Crystal" name and misrepresenting their vapes to British consumers.

  • April 17, 2024

    Intel Urges Court To Revoke Semiconductor's Chip Patent

    Computer processor giant Intel denied infringing the intellectual property of R2, telling a judge Wednesday that the chip patent that the semiconductor maker is trying to enforce is invalid because it represents developments already known in the industry.

  • April 17, 2024

    Toto's Toilet Patent Flushed Over Obviousness

    A Japanese toilet maker failed to secure a patent for a cleaning device placed above toilet seats, after European officials ruled that a skilled person would have eventually combined previous inventions to make its key features.

  • April 24, 2024

    Fieldfisher Goes On German Media, Tech And IP Hiring Spree

    Fieldfisher LLP has recruited 11 lawyers across its German offices, including several new partners, to boost its intellectual property offerings, and strengthen its position in the media sector.

  • April 16, 2024

    IBM Gained Most AI Patents By Far In 2023

    IBM obtained more U.S. artificial intelligence patents in 2023 than any other company, with its closest competitors falling behind by more than 300 patents, according to a Harrity Patent Analytics report announced Tuesday.

  • April 16, 2024

    Granta Can't Patent Purported Chemical Composition Checker

    Ansys Granta can't patent a system that it asserted could estimate the chemical composition of products ranging from toys to engines, as European officials have ruled that the system merely carries out math calculations based on prestored information rather than solving a technical problem.

Expert Analysis

  • Vaccine IP Under Microscope With Coronavirus Outbreak

    Author Photo

    The coronavirus global outbreak, which has focused attention on the role patent systems play in encouraging investment in vaccines and cures, affords an opportunity to examine the tension among patent rights, investments, governments and public health, say Gaby Longsworth and Robert Greene Sterne at Sterne Kessler.

  • EU Lacks Effective Tool For Resolving Border Disputes

    Author Photo

    The European Court of Justice recently found that it did not have jurisdiction over Slovenia's claim to enforce an arbitration award against Croatia, indicating that EU legal framework cannot be used to resolve intra-EU border disputes, and that a new mechanism should possibly be developed, says Akshay Sewlikar at Linklaters.

  • Rebuttal

    AI Can't Accurately Predict Case Length And Cost — Yet

    Author Photo

    A recent Law360 guest article argued that artificial intelligence can precisely estimate the length and cost of a new case, but several limitations will likely delay truly accurate predictions for years to come, says Andrew Russell at Shaw Keller.

  • Trade Agreements With EU Will Still Be Elusive Post-Brexit

    Author Photo

    Although a post-Brexit transitional arrangement largely preserves the status quo between the U.K. and the EU through the end of the year, intense trade negotiations for key industries are still to come, with the possibility of a no-deal exit in 2021, say attorneys at Baker Botts.

  • Surefire Marketing Methods To Build Your Legal Practice

    Author Photo

    Attorneys who take the time and the risk to showcase their talents through speaking, writing and teaching will find that opportunities will begin building upon themselves, says Daniel Karon of Karon LLC.

  • Some Clarity On Inventor-Employee Compensation In The UK

    Author Photo

    The recent U.K. Supreme Court decision in Shanks v. Unilver swept away a perception that some employers are simply too big to pay inventor compensation under the U.K.’s statutory compensation provisions, and may offer some hope to prospective employees, say attorneys at Haseltine Lake.

  • The Rise Of Patent Wars In Europe's Gene Therapy Space

    Author Photo

    Drug companies can prepare for increasing competition and a rise in contentious patent proceedings in Europe’s gene therapy industry by aligning patents, orphan designations and data exclusivity where possible, say Jane Hollywood and Frances Denney of CMS Legal.

  • Self-Driving Vehicles' Neural Networks Present IP Conundrum

    Author Photo

    While autonomous vehicles' use of artificial intelligence through neural networks is highly innovative, the position of these networks within intellectual property has yet to be cemented, and a debate is ongoing as to whether they are best protected by patent, database rights or copyright, say Rajvinder Jagdev and Lin Liu of Powell Gilbert.

  • Failure To Launch: The Patent Thicket Delay Of US Biosimilars

    Author Photo

    Almost 10 years after enactment of the Biologics Price Competition and Innovation Act, AbbVie’s assertion of 18 patents against three Humira biosimilars shows that patent thickets remain an obstacle to launching follow-on biologics and help explain why U.S. launches lag behind those in Europe, say attorneys at Axinn.

  • Huawei Case Might Mean UK Forum Sets Global FRAND Rates

    Author Photo

    The U.K. Supreme Court’s eventual opinion in Unwired Planet v. Huawei will decide whether English courts are a proper forum for determining global fair license terms for standard-essential patents, and there are several reasons to question the English courts' creation of this approach, says Thomas Cotter of the University of Minnesota Law School.

  • Must Inventors Be Humans? An Active Debate Over AI Patents

    Author Photo

    With the first international patents naming artificially intelligent algorithms as inventors filed this summer, and with the U.S. Patent and Trademark Office’s query into whether inventorship laws and regulations need revising, the debate over AI is testing the boundaries of patent laws in the U.S. and elsewhere, says Christian Mammen of Womble Bond.

  • Henry Schein Case Illuminates Maze Of Arbitrability Questions

    Author Photo

    While the U.S. Supreme Court’s Henry Schein decision strengthens the enforceability of arbitration provisions, the Fifth Circuit’s ruling on remand concerning arbitrability authority, exemplifies a need for careful drafting of arbitration clauses, say Andrew Behrman and Brandt Thomas Roessler at Baker Botts.

  • Using Global Dossier To Simplify USPTO Disclosure Duty

    Author Photo

    The U.S. Patent and Trademark Office can make compliance with its duty of disclosure less burdensome by allowing applicants to submit a list of patent families that are believed to have material information and defining electronically available records broadly to include the Global Dossier, whose use the USPTO recently encouraged, says Brian Dorini of InterDigital CE Holdings.

  • The Unique Challenges Of Owning International Cannabis IP

    Author Photo

    Due to the cost of prosecuting patents and the uncertainty in obtaining and enforcing cannabis patents in foreign jurisdictions, building a global cannabis patent portfolio presents complex strategic questions, says Jayashree Mitra of Zuber Lawler.

  • IP Protection Still Elusive For Data Compilations In US And EU

    Author Photo

    As businesses continue to increase investment into artificial intelligence systems, questions arise as to whether they can own or legally protect data compiled by those systems. Currently, in the U.S. and EU, obtaining copyright protection for databases is difficult and trade secret protection requires policies and procedures to establish rights, say attorneys at Mayer Brown.

Want to publish in Law360?

Submit an idea

Have a news tip?

Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!